Text Size

Neighborhoods, Networks, Depression, and HIV Risk (Workshop)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Carl Latkin, Johns Hopkins Bloomberg School of Public Health
ClinicalTrials.gov Identifier:
NCT01380613
First received: March 7, 2011
Last updated: July 16, 2012
Last verified: July 2012
History of Changes
  Purpose

The goal of this study is to examine how social networks, neighborhood, and depression are related to HIV risk. The intervention is designed to train individuals to cope with feelings of depression or stress as a way to reduce their risk for HIV.


Condition Intervention Phase
HIV
Depression
Drug Use
 Behavioral: Workshop
Behavioral: Workshop control
 Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: The Impact of Neighborhoods, Networks, and Depression on Drug Users' HIV Risk

Resource links provided by NLM:

MedlinePlus related topics: Depression HIV/AIDS
U.S. FDA Resources

Further study details as provided by Johns Hopkins Bloomberg School of Public Health:

Primary Outcome Measures:
  • Change from Baseline in Depressive Symptoms Measured by the CESD Scale at 6 months [ Time Frame: 6 months ] [ Designated as safety issue: No ]
  • Change from Baseline in Depressive Symptoms Measured by the CESD Scale at 12 months [ Time Frame: 12 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Change from Baseline in Sex Risk Behavior Based on Number of Sex Partners and Condom Use at 6 months [ Time Frame: 6 months ] [ Designated as safety issue: No ]
  • Change from Baseline in Injection Risk Behavior Based on Sharing Needles, Cookers, and Cotton For Injection and Drug Splitting at 6 months [ Time Frame: 6 months ] [ Designated as safety issue: No ]
  • Change from Baseline in Sex Risk Behavior Based on Number of Sex Partners and Condom Use at 12 months [ Time Frame: 12 months ] [ Designated as safety issue: No ]
  • Change from Baseline in Injection Risk Behavior Based on Sharing Needles, Cookers, and Cotton For Injection and Drug Splitting at 12 months [ Time Frame: 12 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 1000
Study Start Date: September 2007
Estimated Study Completion Date: May 2013
Estimated Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Standard HIV information
Participants receive HIV/STDs risk reduction information.
 Behavioral: Workshop control
1 session intervention on standard HIV/STD information
Experimental: Cognitive Behavioral Therapy
Participants learn skills to cope with depressive symptoms and stress as well as safer sex and injection skills.
 Behavioral: Workshop
10 session intervention

  Eligibility

Ages Eligible for Study:   18 Years to 55 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. 18-55 years old
  2. HIV Risk Behavior:

3a. Injected drugs more than 3 times in the past week OR

3b. Snorted/sniffed heroin or cocaine or smoked crack in the past 6 months AND had 1 of the following sex risks in the past 6 months: i) 2 or more sex partners ii) Had a sex partner who injected drugs iii)Had a sex partner who smoked crack iv) Had a sex partner who was HIV+

4. Willingness to attend group sessions

Exclusion Criteria:

  1. Enrolled in another HIV behavioral intervention or depression study in past the 3 years
  2. Enrolled in another Lighthouse study in past the 5 years
  3. Enrolled in the formative research (Phase 1) or pilot (Phase 2) of the current project.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01380613

Locations
United States, Maryland
Lighthouse Studies @ Peer Points- JHSPH
Baltimore, Maryland, United States, 21205
Sponsors and Collaborators
Johns Hopkins Bloomberg School of Public Health
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Carl A Latkin, PhD Johns Hopkins Bloomberg School of Public Health
  More Information

No publications provided

Responsible Party: Carl Latkin, Professor, Johns Hopkins Bloomberg School of Public Health
ClinicalTrials.gov Identifier: NCT01380613     History of Changes
Other Study ID Numbers: DESPR-DA022961-03, R01-022961-03
Study First Received: March 7, 2011
Last Updated: July 16, 2012
Health Authority: United States: Federal Government

Keywords provided by Johns Hopkins Bloomberg School of Public Health:
HIV
depression
drug use,
risk reduction

Additional relevant MeSH terms:
Depression
Depressive Disorder
Behavioral Symptoms
Mood Disorders
Mental Disorders

ClinicalTrials.gov processed this record on March 05, 2013